Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Kedudukan dalam Saham #40612
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Harga Saham
$0.13607016
Disegerakkan terakhir: 2024-09-10
Modal Pasaran
$112.29K
Perubahan (1 hari)
22.46%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan BiVictriX Therapeutics Plc (BVX)

Kategori

Nisbah P/S bagi BiVictriX Therapeutics Plc (BVX)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini BiVictriX Therapeutics Plc, nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk BiVictriX Therapeutics Plc dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE